New
HealthMore in Health→
Definium's LSD Therapy Eases Anxiety in Second Large Trial
Key Takeaways
- Definium reported that its LSD-based therapy eased anxiety in a second large clinical trial, according to STAT.
- The result is a late-stage replication signal, which regulators and clinicians typically require before approving a new treatment.
- The finding arrives as the first wave of psychedelic-focused biotechs nears potential regulatory approval.
- Psychedelic-assisted treatments are studied as short supervised courses that appear to deliver rapid benefits, unlike daily medications that take weeks to work.
DE
DT Editorial Team··via statnews.com